Rezultaty - Kenji Maeda

American Football Sets Players' Body Mass Index od Kenji Maeda BS, George Moll MD, PhD

Connect to this object online.

Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate meta... od Naoki Amada, Yusuke Kakumoto, Takashi Futamura, Kenji Maeda

Connect to this object online.

Terapia Expulsiva Medicamentosa na Litíase Ureteral: Revisão de Literatura/ Medicamental Expulsive Therapy in Ureteral Lithiasis: Literature Review od Kenji Maeda Missima, Julius de Lima Pedroso, Rodrigo Teixeira Siniscalchi

Connect to this object online.

Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole od Tetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, Tsuyoshi Hirose, Takashi Futamura, Robert D. McQuade

Connect to this object online.

Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice od Naoki Amada, Tsuyoshi Hirose, Mikio Suzuki, Yusuke Kakumoto, Takashi Futamura, Kenji Maeda, Tetsuro Kikuchi

Connect to this object online.

Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse models od Naoki Amada, Shinji Sato, Dai Ishikawa, Mai Nakamura, Mikio Suzuki, Takashi Futamura, Kenji Maeda

Connect to this object online.

Clozapine Prevents a Decrease in Neurogenesis in Mice Repeatedly Treated With Phencyclidine od Kenji Maeda, Haruhiko Sugino, Tsuyoshi Hirose, Hisashi Kitagawa, Taku Nagai, Hiroyuki Mizoguchi, Kazuhiro Takuma, Kiyofumi Yamada

Connect to this object online.

Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5‐HT2A receptors in rats od Naoki Amada, Hitomi Akazawa, Yuta Ohgi, Kenji Maeda, Haruhiko Sugino, Nobuyuki Kurahashi, Tetsuro Kikuchi, Takashi Futamura

Connect to this object online.

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan od Junko Terada-Hirashima, Yuki Takamatsu, Yosuke Shimizu, Yukari Uemura, Junko S. Takeuchi, Noriko Tomita, Kouki Matsuda, Kenji Maeda, Shohei Yamamoto, Ami Fukunaga, Norio Ohmagari, Ayako Mikami, Kengo Sonoda, Mugen Ujiie, Hiroaki Mitsuya, Wataru Sugiura

Connect to this object online.